A detailed history of Stephens Inc transactions in Glaukos Corp stock. As of the latest transaction made, Stephens Inc holds 1,797 shares of GKOS stock, worth $271,131. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,797
Previous 2,897 37.97%
Holding current value
$271,131
Previous $342,000 31.58%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$113.62 - $135.39 $124,982 - $148,928
-1,100 Reduced 37.97%
1,797 $234,000
Q2 2024

Aug 06, 2024

SELL
$89.48 - $118.35 $536 - $710
-6 Reduced 0.21%
2,897 $342,000
Q1 2024

May 15, 2024

SELL
$76.4 - $96.33 $331,652 - $418,168
-4,341 Reduced 59.93%
2,903 $273,000
Q4 2023

Feb 13, 2024

SELL
$59.53 - $85.11 $384,028 - $549,044
-6,451 Reduced 47.1%
7,244 $575,000
Q3 2023

Nov 14, 2023

SELL
$69.23 - $79.09 $79,406 - $90,716
-1,147 Reduced 7.73%
13,695 $1.03 Million
Q2 2023

Aug 14, 2023

SELL
$45.44 - $71.21 $135,638 - $212,561
-2,985 Reduced 16.74%
14,842 $1.06 Million
Q1 2023

May 15, 2023

BUY
$43.88 - $52.48 $324,799 - $388,456
7,402 Added 71.0%
17,827 $893,000
Q4 2022

Jan 25, 2023

BUY
$40.82 - $57.75 $191,486 - $270,905
4,691 Added 81.81%
10,425 $455,000
Q3 2022

Nov 02, 2022

SELL
$46.84 - $58.49 $17,705 - $22,109
-378 Reduced 6.18%
5,734 $305,000
Q2 2022

Aug 03, 2022

SELL
$34.86 - $63.77 $11,120 - $20,342
-319 Reduced 4.96%
6,112 $278,000
Q1 2022

May 04, 2022

BUY
$44.33 - $57.82 $1,507 - $1,965
34 Added 0.53%
6,431 $372,000
Q4 2021

Mar 07, 2022

BUY
$40.27 - $56.99 $19,128 - $27,070
475 Added 8.02%
6,397 $284,000
Q3 2021

Oct 27, 2021

BUY
$47.43 - $84.23 $125,120 - $222,198
2,638 Added 80.33%
5,922 $285,000
Q2 2021

Aug 12, 2021

BUY
$73.06 - $97.7 $239,929 - $320,846
3,284 New
3,284 $279,000
Q3 2019

Oct 18, 2019

SELL
$58.58 - $83.91 $403,733 - $578,307
-6,892 Closed
0 $0
Q2 2019

Aug 01, 2019

SELL
$63.59 - $78.71 $67,977 - $84,140
-1,069 Reduced 13.43%
6,892 $520,000
Q1 2019

May 03, 2019

BUY
$50.75 - $80.54 $404,020 - $641,178
7,961 New
7,961 $624,000
Q4 2018

Feb 11, 2019

SELL
$52.18 - $67.93 $168,332 - $219,142
-3,226 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$38.13 - $68.37 $123,007 - $220,561
3,226 New
3,226 $209,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Stephens Inc Portfolio

Follow Stephens Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.